ABOUT OUR COMPANY
We believe conquering cancer is a big data problem. That's why we built the world's leading comprehensive liquid biopsy.
This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. We're working on some exciting ones, including in early detection, where the impact on patients can be profound. We've raised more than $500 million from investors including Sequoia Capital, Khosla Ventures, OrbiMed, and SoftBank.
Requires Master's degree in Bioinformatics plus 2 years of
experience as Manager, Bioinformatics Software Quality Assurance
Engineering or Sr. Software Test Engineer. The candidate must have minimum
two (2) years of experience in the following: developing and maintaining test
automation scripts, and framework for testing web applications, instrumentation
software, SQL databases, application programming interfaces (API), and
genetic data analysis applications using tools like Test Studio, coded UI and
custom scripts in C#, Perl, and Python; creating, managing, analyzing, and
documenting test plans, test cases, defects, requirement traceability matrix, test
results, and corrective action using Team Foundation Server (TFS), JIRA,
JAMA, Confluence, and Document Control Systems; analyzing next generation
sequencing data to establish and create data sets that test edge scenarios and
negative scenarios using Next Generation Sequencing tools bwa, samtools,
and IGV in an agile environment; maintaining source code in source control
repositories including TFS and GitHub; and establishing and maintaining
function-based relationships within cross functional groups and reporting
overall test effort.
All your information will be kept confidential according to EEO guidelines.
Guardant Health, Inc.